BBTS Annual Conference 2012 Presentations
The following speakers have given their permission for their presentations to be made available
Wednesday 26 September
Red Cell 1
Transfusion Medicine & KODE Technology: R&D tools, QC Systems, diagnostics and therapeutics
The pathophysiology of sickle cell disease
Hospital Transfusion
The appropriate use of red cell transfusion in medical patients: results of the National Comparative Audit
The challenges of long term transfusion
Blood Components
Learning to love your regulator - living with the US FDA
Home truths - the use of blood components in the UK
Red Cell 2
Some observations on haemoglobin A2
Apheresis and Blood Collection
Blood Group Education -'Starting the conversation'
Irish Success stories
Paediatrics
Transfusion associated necrotizing enterocolitis - is there a casual link?
Red Cell 3
The role of flow cytometry in diagnosis and monitoring of patients with paroxysmal nocturnal haemoglobinuria
Blood Bank Technology
Appearance of Anti-D in a 4 year old apparently transfused only RhD negative components
Haemolytic transfusion reactions with no cause? Keep calm and carry on
Microbiology
Beating the bugs: exploring the options to improve platelet transfusion
Bacterial screening of platelet components in NHSBT - was it worth it?
Plenary 1: Ethics and Consent
Consent for cord blood
Consent for blood donation
Consent for blood transfusion
The Tipping Point - consent in organ donation
Consent for transfusion - an online education resource
Thursday 26 September
Education session II
How to write a good abstract
Clinical management of adverse reactions in transfusion
Plenary II - Award Lectures
To err is human - the evolution of transfusion safety in hospitals
Experienced or Enfeebled? Does red cell storage affect patient outcome?
Sim 1: Rare Phenotype Donors
Rare donors: the French experience
Use of rare blood in complex cases
Orals 1: Clinical Transfusion
Factors associated with platelet wastage in Scottish Hospitals
The development of a blood management programme for Orthopaedic surgery at the Royal Cornwall Hospital Trust
Implementation of a two sample policy for compatibility testing
Orals 2: Clinical Audit
Are major haemorrhage protocols effective? An audit of 4 major trauma centres
A national comparative re-audit of bedside transfusion practice
Control of platelet transfusion in a teaching hospital setting
Using real life scenarios and rrors to improve IQA for all staff involved in transfusion
Requirement for a knowledge-based competency assessment scheme (KBCAS) provided by the UK National External Quality Assessment Scheme (NEQAS) for Blood Transfusion Laboratory Practice (BTLP)
Re-audit of informed consent and patient understanding of blood transfusion
SIM III
Developing an effective incident management system
SIM VI
OSCE assessment tool and its role in the development of HCSW within the Welsh Blood Service
Why is the Care Quality Commission relevant to NHS Blood and Transplant?
Leading Better Care - the impact of the programme in SNBTS
Demonstrating compliance by showing we care
Plenary III
vCJD - where are we now?
An assay for vCJD: are we nearly there yet?
vCJD interventions - how did we get here?
Friday 28 September
Plenary IV
From enucleation to mature erythrocyte: Imaging reticulocyte maturation in vitro
A universal erythrocyte receptor for plasmodium falciparum invasion
SIM VII
Use of incompatible blood in a life-threatening obstetric haemhorrhage
'No transfusion' approach to massive haemhorrhage
A predictive tool for TACO or just common sense?
Renal patient with haemolysis - have we thought of everything?
Balancing the risks: a difficult case of sickle pregnancy
SIM VIII
Platelet production in vitro: the way forward from iPSCs
Use of human induced pluripotent stem cells to derive haematopoietic progenitors for erythropoiesis and red cell production
SIM XI
Orals 3: Miscellaneous
Novel mutations in RHAG causing two new examples of the regulator type of Rhnull
The rare Wr(b-) phenotype arising from a novel mutation in GYPA paired with GP.Hil (Mi.V.)
A serological and molecular study of a novel XK inactivating mutation in McLeod syndrome
Are patients with anti-M being managed appropriately?
SIM X
Identify the need for change using audit
Making change happen
Support for change
SIM XI
Using platelets in haematology: new studies
SIM XII
Trials of several platforms for high-throughput blood group genotyping of donors
BBTS Annual Conference 2013
Next year's conference will take place 16-18 October at Birmingham International Convention Centre
BBTS Annual Conference 2014
2014 Annual Conference will take place 24-26 September at Harrogate International Centre
BBTS Annual Conference 2011 photos >
